D
Tarsus Pharmaceuticals, Inc. TARS
$58.85 $2.243.96% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 19.03% -8.68% 1.31% 29.65% 6.83%
Total Depreciation and Amortization -1.52% 6.48% 52.11% 18.83% -11.48%
Total Amortization of Deferred Charges 5.04% 0.72% 6.98% 27.72% -11.40%
Total Other Non-Cash Items 16.07% -5.06% -5.57% -22.27% 34.93%
Change in Net Operating Assets -756.28% 66.65% -172.42% -22.86% 219.36%
Cash from Operations -42.30% 6.90% -156.38% 39.93% 61.88%
Capital Expenditure -69.66% -719.44% 74.47% 72.86% -497.13%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -47.60% 42.27% -1,844.93% 108.64% 61.31%
Cash from Investing -47.97% 41.35% -2,004.54% 107.72% 60.36%
Total Debt Issued -- -- -- -100.00% --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -98.57% 4,565.60% 331.71% -74.70% -97.30%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 100.00% 99.89% -477.59%
Cash from Financing -98.57% 4,565.60% 358.06% -98.49% -61.09%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -197.74% 202.71% -1,513.69% 61.26% 59.64%